1. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization
- Author
-
Y Perk, N Altinkaya, N Köksal, Uludaǧ Üniversitesi/Tıp Fakültesi/Cocuk Sağlığı ve Hastalıkları Anabilim Dalı., and Köksal, Nilgün
- Subjects
HBsAg ,Time Factors ,Hepatitis B vaccine ,Pediatrics ,HBsAg antigenemia ,parasitic diseases ,Hepatitis vaccine ,Humans ,Medicine ,Hepatitis B Vaccines ,Prospective Studies ,Hepatitis B Surface Antigens ,business.industry ,Vaccination ,Infant, Newborn ,virus diseases ,General Medicine ,Hepatitis B ,Newborn ,medicine.disease ,Immunogenicity ,Virology ,Neonatal hepatitis ,surgical procedures, operative ,Immunization ,Pediatrics, Perinatology and Child Health ,Viral disease ,Safety ,business - Abstract
Following immunization with hepatitis B vaccine, 39 infants were followed prospectively for hepatitis B surface antigen (HBsAg). A total of 69.2% of the infants tested positive for antigenemia at least once. Antigenemia was identified most often at 2-3 days (43.5%) and 5-6 days (43.5%) after immunization. The longest documented duration of antigenemia was 21 days. In all cases the antigenemia was transient and cleared by the 28th day post-vaccination.
- Published
- 1996